XML 46 R32.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Summary of Stock Option Activity

A summary of the stock option activity under the Hyperfine Plan is presented in the table below:

 

 

 

Number of Options

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term

 

 

Aggregate Intrinsic Value

 

Outstanding at January 1, 2023

 

 

10,719,564

 

 

$

1.34

 

 

 

8.75

 

 

$

157

 

Granted

 

 

5,323,048

 

 

 

1.65

 

 

 

 

 

 

 

Exercised

 

 

(210,234

)

 

 

0.83

 

 

 

 

 

 

 

Forfeited / Expired

 

 

(1,560,791

)

 

 

1.41

 

 

 

 

 

 

 

Outstanding at December 31, 2023

 

 

14,271,587

 

 

$

1.46

 

 

 

8.30

 

 

$

1,764

 

Granted

 

 

5,804,783

 

 

 

0.99

 

 

 

 

 

 

 

Exercised

 

 

(282,823

)

 

 

0.60

 

 

 

 

 

 

 

Forfeited / Expired

 

 

(1,397,011

)

 

 

1.19

 

 

 

 

 

 

 

Outstanding at December 31, 2024

 

 

18,396,536

 

 

$

1.34

 

 

 

 

 

 

 

Options exercisable at December 31, 2024

 

 

8,476,410

 

 

$

1.61

 

 

 

7.11

 

 

$

56

 

Vested or expected to vest at December 31, 2024

 

 

18,396,536

 

 

$

1.34

 

 

 

7.99

 

 

$

95

 

Assumptions Used to Value Option Grants to Employees and Nonemployees The assumptions used to value option grants to employees and nonemployees for the years ended December 31, 2024 and 2023 were as follows:

 

 

 

2024

 

2023

 

Risk Free interest rate

 

3.59% - 4.66%

 

3.32% - 4.8%

 

Expected dividend yield

 

0%

 

0%

 

Expected term

 

5.50 6.76 years

 

5.50 7.50 years

 

Expected volatility

 

55% ─ 66%

 

55% ─ 66%

 

Summary of Stock Options Granted

The stock options granted to the Company’s employees and nonemployees for the periods presented were as follows:

 

 

 

2024

 

 

2023

 

 

Stock options granted to employees

 

 

5,408,783

 

 

 

4,270,611

 

 

Stock options granted to nonemployee directors

 

 

396,000

 

 

 

1,052,437

 

 

Total stock options granted

 

 

5,804,783

 

 

 

5,323,048

 

 

Summary of Restricted Stock Unit Activity The following table summarizes the changes in the Company’s outstanding restricted stock units (“RSUs”) for the year ended December 31, 2024:

 

 

 

Number of
RSUs

 

Outstanding at January 1, 2023

 

 

1,585,359

 

Granted

 

 

29,000

 

Released

 

 

(1,008,283

)

Forfeited

 

 

(237,050

)

Expired

 

 

 

Outstanding at December 31, 2023

 

 

369,026

 

Granted

 

 

 

Released

 

 

(181,694

)

Forfeited

 

 

(48,430

)

Outstanding at December 31, 2024

 

 

138,902

 

Summary of Stock-Based Compensation Expense

The Company’s stock-based compensation expense for the periods presented was as follows:

 

 

 

2024

 

 

2023

 

 

Cost of sales

 

 

83

 

 

 

109

 

 

Research and development

 

 

1,449

 

 

 

1,283

 

 

General and administrative

 

 

2,640

 

 

 

3,162

 

 

Sales and marketing

 

 

190

 

 

 

187

 

 

Total stock-based compensation expense

 

$

4,362

 

 

$

4,741